N-acetylgalactosaminyl GD1a is a target
✍
Susumu Kusunoki; Atsuro Chiba; Kazuo Kon; Susumu Ando; Kazuko Arisawa; Asako Tat
📂
Article
📅
1994
🏛
John Wiley and Sons
🌐
English
⚖ 649 KB
Serum antibodies against such major glycolipids as GMI, GDlb, and LM1 have been reported in patients in the acute phase of Guillain-Barre syndrome (GBS). Because minor unidentified glycolipids also may be targets of antibodies in GBS sera, we assayed serum antibody against a crude ganglioside fracti